Seres Therapeutics, Inc. (MCRB) vs Rockwell Medical, Inc. (RMTI)

A side-by-side comparison of Seres Therapeutics, Inc. and Rockwell Medical, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — MCRB vs RMTI

growth of $100 · dividends reinvested · last 10y
MCRB -98.8% (-35.7%/yr)RMTI -98.9% (-36.3%/yr)MCRB compounded faster over this window
0100200300Start $10020182020202220242026$1$1
MCRB RMTI

MCRB vs RMTI: by the numbers

  • •RMTI is the larger company ($30M vs $28M market cap).
  • •Both run net losses; RMTI's is the smaller (-7.33% vs -1192.94% net margin).
  • •RMTI grew revenue faster over the past five years (2.59% vs -42.51% CAGR).

Metrics side by side

Valuation

MetricMCRBRMTI
P/S ratio14.910.44
P/B ratio0.810.86
FCF yieldN/A5.10%

Profitability

MetricMCRBRMTI
Gross margin-423.83%17.71%
Operating margin-11910.14%-6.52%
Net margin-1192.94%-7.33%
ROE-65.05%-14.49%
ROIC-103.04%-9.60%

Growth (annualized)

MetricMCRBRMTI
Revenue CAGR (5Y)-42.51%2.59%
Total return CAGR (5Y)-53.37%-33.38%

Frequently asked

Which has grown faster, MCRB or RMTI?
Over the past five years, RMTI grew revenue faster — MCRB at a -42.51% CAGR versus RMTI at 2.59%.
How have MCRB and RMTI total returns compared?
Over the past 10 years, MCRB delivered -35.85% and RMTI delivered -36.28% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.